Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 8;2017(1):152-159.
doi: 10.1182/asheducation-2017.1.152.

Iron deficiency in gynecology and obstetrics: clinical implications and management

Affiliations
Review

Iron deficiency in gynecology and obstetrics: clinical implications and management

Christian Breymann et al. Hematology Am Soc Hematol Educ Program. .

Abstract

Iron deficiency is the commonest cause of anemia during pregnancy; however, its prevalence is highly determined by nutritional and socioeconomic status. Oral iron is the frontline therapy, but is often poorly tolerated. Awareness of the available intravenous formulations is essential for management. Before delivery, risk factors such as multiparity and heavy uterine bleeding increase the prevalence of iron deficiency and should be motivation for early diagnosis and treatment. Neonates born with iron deficiency have a statistically significant increment in both cognitive and behavioral abnormalities that persist after repletion, highlighting the need for heightened awareness of the diagnosis. A smartphone application providing information on nutrition and treatment is provided. New formulations of intravenous iron with carbohydrate cores, which bind elemental iron more tightly, minimize the release of labile free iron to allow complete replacement doses of intravenous iron in 15 to 60 minutes, facilitating and simplifying care.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: C.B. has consulted for and received honoraria from Vifor International Company. M.A. has received research funding from AMAG Pharma, Pharmacosmos, and Luitpold and has consulted for AMAG Pharma and Pharmacosmos.

Figures

Figure 1.
Figure 1.
The FER-ASAP Study. Reprinted from Breymann et al with permission.
Figure 2.
Figure 2.
Change in hemoglobin and TSAT. Reprinted from Auerbach et al with permission.

References

    1. Milman N. Anemia--still a major health problem in many parts of the world! Ann Hematol. 2011;90(4):369-377. - PubMed
    1. Akabas SR, Dolins K. Micronutrient requirements of physically active women: what can we learn from iron? Am J Clin Nutr. 2005;81(5):1246S-1251S. - PubMed
    1. Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128(3):196-200. - PubMed
    1. Gao J, Zeng S, Sun BL, Fan HM, Han LH. Menstrual blood loss and hematologic indices in healthy Chinese women. J Reprod Med. 1987;32(11):822-826. - PubMed
    1. Allen LH. Pregnancy and iron deficiency: unresolved issues. Nutr Rev. 1997;55(4):91-101. - PubMed